Home > Financial Ratios > PIRAMAL PHARMA

PIRAMAL PHARMA
Price to Cash Earnings (PCE)

    Back to All Ratios
COMMUNITY POLL
for PIRAMAL PHARMA
Please provide your vote to see the results

PIRAMAL PHARMA Last 5 Year Price to Cash Earnings (PCE) History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   PCE(x) 35.8432.7622.4916.66-

What is the latest Price to Cash Earnings (PCE) ratio of PIRAMAL PHARMA ?

The latest Price to Cash Earnings (PCE) ratio of PIRAMAL PHARMA is 35.84 based on Mar2026 Consolidated results.
Year Price to Cash Earnings (PCE)
Mar202635.84
Mar202532.76
Mar202422.49
Mar202316.66
Mar2022-

How is Price to Cash Earnings (PCE) of PIRAMAL PHARMA Trending?

Years Price to Cash Earnings (PCE) % Change
Mar2026 35.84
9.40
Mar2025 32.76
45.66
Mar2024 22.49
34.99
Mar2023 16.66
0
Mar2022 0 -

Other Financial Ratios of PIRAMAL PHARMA


Compare Price to Cash Earnings (PCE) ratio of peers of PIRAMAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
PIRAMAL PHARMA ₹22,885.0 Cr -2.3% 1.8% -17.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹465,195.0 Cr 1.8% 9% 12.5% Stock Analytics
DIVIS LABORATORIES ₹180,823.0 Cr 0.8% 0.8% -1.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹165,725.0 Cr 2.8% 9.5% 45.4% Stock Analytics
CIPLA ₹116,467.0 Cr -1.2% 4.7% -4.4% Stock Analytics
DR REDDYS LABORATORIES ₹105,987.0 Cr -7.6% 0.1% 6.1% Stock Analytics


PIRAMAL PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
PIRAMAL PHARMA

-2.3%

1.8%

-17.7%

SENSEX

-1%

4.4%

-8.3%


You may also like the below Video Courses